Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unit

Journal of Hospital Infection

Volumn 56, Issue 3, 2004, Pages 175-183

  de la Cal, M A ^a   Cerda E ^a   van Saene, H K F ^b   Garcia Hierro P ^a   Negro, E ^a   Parra, M L ^a   Arias, S ^a   Ballesteros, D ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Infection control; Intensive care unit; MRSA; Nosocomial infection; Vancomycin; Vancomycin Resistant enterococcus

Indexed keywords

AMPHOTERICIN B; CEFOTAXIME; COLISTIN; EUCERINUM; GLYCOPEPTIDE; METICILLIN; NEOMYCIN; POLYMYXIN; PSEUDOMONIC ACID; TOBRAMYCIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM CARRIER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST; DRUG EFFICACY; DRUG SAFETY; DRUG SENSITIVITY; ENDEMIC DISEASE; ENTEROCOCCUS; EPIDEMIC; FEMALE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION CONTROL; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PATIENT CARE; PREVALENCE; PROSPECTIVE STUDY; SIDE EFFECT;

AGED; ANTI-BACTERIAL AGENTS; DRUG ADMINISTRATION ROUTES; ENDEMIC DISEASES; FEMALE; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 1342286310     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2003.09.021     Document Type: Article

References (38)

1. Working Party report Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infections in hospitals J Hosp Infect 39 1998 253-290
2. Chaix C. Durand-Zaleski I. Alberti C. Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit JAMA 282 1999 1745-1751
3. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 1994;44:1-12.
4. Smith T.L. Pearson M.L. Wilcox K.R. et al. for the glycopeptide-intermediate Staphylococcus aureus working group. Emergence of vancomycin resistance in Staphylococcus aureus N Engl J Med 340 1999 493-501
5. Edmond M.B. Wenzel R.P. Pasculle W. Vancomycin-resistant Staphylococcus aureus: perspectives on measures needed for control Ann Intern Med 124 1996 329-334
6. Boyce J.M. Jackson M.M. Pugliese G. the AHA Technical Panel on Infections within Hospitals et al. Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospital and nursing facilities Infect Control Hosp Epidemiol 15 1994 105-115
7. Barrett S.P. Mummery R.V. Chattopadhyay A. Trying to control MRSA causes more problems than it solves J Hosp Infect 39 1998 85-93
8. Voss A. Miltovic D. Wallrauch-Schwartz C. Rosdhal V.T. Braveny I. Methicillin-resistant Staphylococcus aureus in Europe Eur J Clin Microbiol Infect Dis 13 1994 50-55
9. Brun-Buisson C. Legrand P. Rauss A.F. et al. Intestinal decontamination for control of nosocomial multiresistant Gram-negative bacilli Ann Intern Med 110 1989 873-881
10. Taylor M.E. Oppenheim B.A. Selective decontamination of the gastrointestinal tract as an infection control measure J Hosp Infect 17 1991 271-278
11. Damjanovic V. Connolly C.M. van Saene H.K.F. et al. Selective decontamination with nystatin for control of a candida outbreak in a neonatal intensive care unit J Hosp Infect 24 1993 245-259
12. Coello R. Jimenez J. Garća M. et al. Prospective study of infection, colonisation and carriage of methicillin-resistant Staphylococcus aureus affecting 900 patients Eur J Clin Microbiol Infect Dis 13 1994 74-81
13. Walsh B. Salzman M. Gaunt N. et al. Methicillin resistant Staphylococcus aureus Lancet ii 1985 219-220
14. Rimland D. Roberson B. Gastrointestinal carriage of methicillin-resistant Staphylococcus aureus J Clin Microbiol 24 1986 137-138
15. Brady L.M. Thomson M. Palmer M.A. Harknes J.L. Successful control of endemic MRSA in a cardiothoracic surgical unit Med J Aust 152 1990 240-245
16. Shahin R. Johnson I.L. Jamieson F. Mc Geer A. Tolkin J. Fors-Jones E.L. Methicillin-resistant Staphylococcus aureus carriage in a child care center following a case of disease Arch Pediatr Adolesc Med 153 1999 864-868
17. Tedesco F. Marlham R. Gurwith M. Christie D. Barlett J.G. Oral vancomycin for antibiotic-associated pseudomembranous colitis Lancet ii 1978 226-228
18. Khan M.Y. Hall W.H. Staphyloccocal enterocolitis-treatment with oral vancomycin Ann Intern Med 65 1996 1-8
19. Garner J.S. Hospital Infection Control Practices Advisory Committee Guideline for isolation precautions in hospitals Infect Control Hosp Epidemiol 17 1996 53-80
20. Liberati A. D' Amico R. Pifferi S. et al. Antibiotics for preventing respiratory tract infections in adults receiving intensive care (Cochrane Review) The Cochrane Library Issue 4 2003 John Wiley - Sons Chichester, UK
21. van Uffelen R. van Saene H.K.F. Fidler V. Löwenberg A. Oropharyngeal flora as a source of bacteria colonizing the lower airways in patients on artificial ventilation Intens Care Med 10 1984 233-237
22. Wenzel R.P. Reagan D.R. Bertino J.S. Baron E.J. Arias K. Methicillin-resistant Staphylococcus aureus outbreak: a consensus panel's definition and management guidelines Am J Infect Control 26 1998 102-110
23. Sarginson R.E. Taylor N. van Saene H.K.F. Glossary of terms and definitions Curr Anaesth Crit Care 12 2001 2-5
24. Van Saene H.K.F. Damjanovic V. Murray A.E. de la Cal M.A. How to classify infections in intensive care units-the carrier state, a criterion whose time has come J Hosp Infect 33 1996 1-12
25. Intensive care antimicrobial resistance epidemiology (ICARE) surveillance report, data summary from January 1996 through December 1997. Am J Infect Control 1999;27:279-284.
26. Leonard E.M. van Saene H.K.F. Shears P. Walker J. Tam P.K. Pathogenesis of colonization and infection in a neonatal surgical unit Crit Care Med 18 1990 264-269
27. National Committee for Clinical Laboratory Standards Performance standards for antimicrobial susceptibility testing NCCLS approved standard M100-S9 1999 National Committee for Clinical Laboratory Standards Wayne, P
28. Hendrix C.W. Hammond J.M.J. Swoboda S.M. et al. Surveillance strategies and impact of vancomycin-resistant enterococcal colonization and infection in critically ill patients Ann Surg 233 2001 259-265
29. Isenberg Clinical microbiology procedures handbook 1992 American Society of Microbiology Washington DC
30. Bernard P.M. Lapointe C. Mesures statistiques en épidémiologie 1987 Presses de l'Université du Québec Québec
31. Hennekens CH, Buring JE. Measures of disease frequency and association. Analysis of epidemiologic studies: evaluating the role of chance. In: Mayrent SL, editor. Epidemiology in Medicine, 1st edn. Boston: Little, Brown and Company: 1987. p. 77-96, 254-257.
32. Cox R.A. Conquest C. Mallaghan C. Marples R.R. A major outbreak of methicillin-resistant Staphylococcus aureus caused by a new phage-type (EMRSA-16) J Hosp Infect 29 1995 87-106
33. Harbarth S. Dharan S. Liassine N. Herrault P. Auckenthales R. Pittet D. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 43 1994 1412-1416
34. Siu Y.K. Fung S.C. Lee C.H. et al. Double blind, randomised, placebo controlled study of oral vancomycin in prevention of necrotising enterocolitis in preterm, very low birthweight infants Arch Dis Child Neonatal 79 1998 105-109
35. Chadwick P.R. Chadwick C.D. Oppenheim B.A. Report of a meeting on the epidemiology and control of glycopeptide-resistant enterococci J Hosp Infect 33 1996 83-92
36. Geraci J.E. Some laboratory and clinical experiences with a new antibiotic, vancomycin Staff Meetings of the Mayo Clinic 31 1956 564-582
37. Ferrer M. Torres A. Gonález J.M. et al. Utility of selective digestive decontamination in mechanically ventilated patients Ann Intern Med 120 1994 389-395
38. Silvestri L. Milanese M. Oblach L. et al. Enteral vancomycin to control methicillin-resistant Staphylococcus aureus outbreak in mechanically ventilated patients Am J Infect Control 30 2002 391-399